- [PRESSWIRE] Parma – 10 July, 2018 — An Indian working group published five cases of nephrotic syndrome caused by MN with evidence of chronic mercury poisoning due to consumption of traditional Indian medicines such as Siddha and Ayurveda. The article was published in “Clinical Kidney Journal” (ckj), an official journal of the ERA-EDTA. “As long as there are no strict quality controls for substances used in traditional medicine, we have to warn our patients: Mercury poisoning can lead to MN as well as to many other severe health problems, affecting the brain, the gut and the kidneys.”
- [PRESSWIRE] Franklin, IN – 09 July, 2018 — G&H Orthodontics is a full line manufacturer of orthodontic products. G&H has supplied Orthodontists worldwide with the best products on the market for over 40 years. We are proud of the reputation that we have garnered in the industry and continue to look for ways to bring quality products to our customers. For this reason, we are excited to announce our collaboration with Premier Dental, and to offer our customers even more outstanding treatment options.
- [PRESSWIRE] ‘s-Hertogenbosch, The Netherlands – 5 July, 2018 — A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The EUROSTARS project is titled “Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis” and named IMMUNOMONITOR.
- [PRESSWIRE] Parma – 29 June, 2018 — The ERA-EDTA and the Japanese Society of Nephrology (JSN) are delighted to announce continuing progress in their joint collaboration in the important field of mineral and bone disorder in chronic kidney disease (CKD-MBD). This serious condition affects most people as their kidney disease progresses.
- [PRESSWIRE] Germany – 27 June, 2018 — Kidney diseases have so far been underestimated in many respects: most people are not aware of their impaired kidney function. In general, kidney diseases are “silent diseases”, most often there are no apparent early symptoms. Many people with kidney diseases are not aware that they have been living with higher risks of cardiovascular diseases, infections, hospitalizations, and of course kidney failure which requires dialysis or transplantation.
- [PRESSWIRE] SEATTLE, June 22, 2018 — LumiThera Inc., a commercial stage medical device company focused on developing non-invasive Photobiomodulation (PBM) therapies for ocular disorders and disease, announced CE Mark Certification for the European Union (EU) for the treatment of dry age-related macular degeneration (AMD) utilizing its LT-300 Light Delivery System.
- [PRESSWIRE] Boston, MA – June 12, 2018 — Zaluvida a global life science group, announced today the formation of a Scientific Advisory Board (SAB) to inform the Human Health Research & Development department about the latest research, scientific methods, and opportunities for weight-loss management, and help further technology and product development for the company.
- [PRESSWIRE] Lisbon, Portugal – 12 June, 2018 — O IV Congress of the European Academy of Neurology (EAN) terá lugar no Centro de Congressos de Lisboa, em Lisboa, de 16 a 19 de junho. Este importante evento científico atrairá milhares de participantes de países europeus e não europeus.
- [PRESSWIRE] Lisbon, Portugal – 12 June, 2018 — The Fourth Congress of the European Academy of Neurology (EAN) will take place at the Lisboa Congress Centre in Lisbon from 16 to 19 June. This major scientific event will attract thousands of participants from European and non-European countries.
- [PRESSWIRE] WASHINGTON, May 31, 2018 /PRNewswire-USNewswire/ — As part of the upcoming American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, June 1st through the 4th, the Cancer Support Community (CSC), a global nonprofit, will release three new research studies.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — 4-6 million people worldwide are affected by familial cystic kidney disease, the most common inherited kidney disease – accounting for ∼10% of European patients on dialysis or living with a kidney transplant. The range of potential therapies is still limited, so other novel therapy options are urgently needed.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — A late breaking clinical study [1] at the ERA-EDTA Congress in Copenhagen showed that the phosphate binder ferric citrate improves multiple aspects of abnormal mineral metabolism and raises hemoglobin in patients with advanced chronic kidney disease (CKD), who do not have abnormal levels of blood phosphate or anemia.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — The prevalence of chronic kidney disease (CKD) is relatively high, at approximately 10% of the population, but only relatively few patients have endstage renal disease and require renal replacement therapy.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — Over a third of systemic lupus erythematosus (SLE) patients have kidney involvement (lupus nephritis), and are at risk of end-stage renal disease and premature death. Current therapies are toxic and not routinely effective, so novel therapy options are urgently needed.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — A new analysis [1], published in Nephrology Dialysis Transplantation during this week’s ERA-EDTA Congress in Copenhagen, confirms that a kidney transplant before start of dialysis extends the life of both the patient and the transplanted organ. However, for patients who do not receive a preemptive transplant, the length of time they spend dialysis (dialysis vintage) no longer appears to reduce their life expectancy after transplantation.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — Development of disease is often related to the deregulation of a gene program controlled at the post-transcriptional level by microRNAs (miRNAs). A new review [1], published in Nephrology Dialysis Transplantation during this week’s ERAEDTA Congress in Copenhagen, shows that miRNAs are potential innovative biomarkers, and are promising as groundbreaking drugs. “The review of Laurent Metzinger and colleagues summarizes the current state of art of the research on miRNAs in kidney disease”, explains Professor Denis Fouque, editor-in-chief of Nephrology, Dialysis, Transplantation (NDT).
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — A review [1] published in Nephrology Dialysis Transplantation (NDT) during the ERA-EDTA Congress in Copenhagen highlights the importance of controlling all metabolic risk factors for cardiovascular disease in every potential kidney transplant candidate, both before and after transplantation.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — Klotho, the Greek goddess who spins the thread of life, has become popular among nephrologists, because the genes named after her encode receptors for hormones that play critical roles in the pathophysiology of chronic kidney disease (CKD). Namely, αKlotho and βKlotho function as receptors for two hormones, fibroblast growth factor-23 (FGF23) and FGF21, respectively.
- [PRESSWIRE] Copenhagen, Denmark – 25 May, 2018 — The ERA-EDTA is the leading society in Europe for physicians working in the field of care for patients with kidney disease – and is the first medical association to try and implement ‘greener’ health care as suggested by the ‘Lancet Countdown’. Technical progress, e-health, the support of home and self care schemes and sustainable healthcare education and research are ways to ‘greener’ nephrology.
- [PRESSWIRE] Copenhagen, Denmark – 24 May, 2018 — ERA-EDTA Congress 2018 sees the launch of the ADPKD Patient Route Map, an interactive resource designed to help educate and empower people affected by autosomal dominant polycystic kidney disease (ADPKD).
- [PRESSWIRE] BENTONVILLE, Ark., May 24, 2018 — FirstLight Home Care, an award-winning provider of non-medical home care, today announced it is opening a Bentonville location in The Natural State in June.
- [PRESSWIRE] London, United Kingdom – 21 May, 2018 — Global Voice Group (GVG) a le plaisir d’annoncer la nomination de M. James Gabriel Claude au poste de Directeur général adjoint de la société. M. Claude travaille pour GVG depuis 2005, ayant occupé les postes d’Ingénieur du centre d’exploitation réseau et de Chef de projet avant d’être nommé Vice-président de la technologie en 2013. Au cours de la dernière décennie, il a été activement impliqué dans l’exécution d’importants projets GVG dans de nombreux pays.
- [PRESSWIRE] PALO ALTO, California, May 18, 2018 — ReCor Medical announced today that it will present the primary outcomes data from the SOLO study of its RADIANCE Global Clinical Trial Program of the Paradise® Ultrasound Renal Denervation System for patients with hypertension during the Late Breaker Sessions at the EuroPCR 2018 Meeting in Paris on 23 May.
- [PRESSWIRE] SAN FRANCISCO, May 18, 2018 — Dornier MedTech (Dornier), a global leader in innovative kidney stone management, today announced the launch of Dornier Delta® III SmartLitho™, the world’s first lithotripter system which uses big data in urology, at the American Urology Association (AUA) Annual Meeting 2018.
- [PRESSWIRE] MELBOURNE, Australia, May 18, 2018 — BioScience Managers, one of Australia’s leading international life sciences investment firms, has invested in a new medical device platform through their BioScience Managers Ventures Fund I.
- [PRESSWIRE] SHANGHAI, CAMBRIDGE, Massachusetts and REYKJAVIK, Iceland, April 26, 2018 — WuXi NextCODE, the global standard platform for genomic data, today detailed its plans and progress in building a pioneering global network to improve the diagnosis and treatment of rare disease.
- [PRESSWIRE] GENEVA, April 19, 2018 — The Medicines Patent Pool (MPP) Governance Board today announced the appointment of Charles Gore, founder and former President of the World Hepatitis Alliance, as new MPP Executive Director. Mr. Gore succeeds Greg Perry, Executive Director of the organisation from 2013-2017.
- [PRESSWIRE] RESEARCH TRIANGLE PARK, North Carolina, April 17, 2018 — Marken announced today their plans to develop a global home-based nursing network to supplement Marken’s existing Direct to/from Patient (DTP/DFP) services.
- [PRESSWIRE] SAN DIEGO, April 16, 2018 — Artemis Therapeutics, Inc. (OTCQB: ATMS), (“Artemis” or the “Company”), a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, today announced the decision by the Japanese Patent Office to allow the patent entitled “Methods and Compositions for Treating Viral Infections”.
- [PRESSWIRE] MARLBOROUGH, Mass., April 16, 2018 — Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women’s health.